Tuesday, July 18, 2017 9:07:19 AM
MBRX - 1.70 Pre-market now at 2.05/2.06
Moleculin Signs Agreement with MD Anderson Cancer Center for Leukemia Drug, Annamycin
Moleculin Signs Agreement with MD Anderson Cancer Center for Leukemia Drug, Annamycin
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
